This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
The Nurse's Role in Improving Outcomes in Patients With Pulmonary Arterial Hypertension

The Nurse's Role in Improving Outcomes in Patients With Pulmonary Arterial Hypertension

Format

Clinical Review

Time to Complete

1 hour

Released

May 25, 2017

Expires

May 25, 2018
Add to Queue


Maximum Credits

1.00 / CE for Nurses
1.00 / CE for Nurse Practitioners (1.00 hour of pharmacology credit)

Accredited Provider



Provided by Advancing Knowledge in Healthcare (AKH) Inc.

Commercial Supporter

Supported by Actelion Pharmaceuticals US, Inc. and Bayer HealthCare Pharmaceuticals, Inc.

Program Description

Pulmonary arterial hypertension (PAH) is a progressive disease associated with poor clinical outcomes and poor patient survival despite ongoing advances in treatment. At this time, there is a significant need to educate nurses on pharmacologic options for PAH along with patient-related clinical considerations. The purpose of this activity is to focus on several important aspects of PAH management, including a review of the pathophysiology, classification, predictors of disease progression, and clinical outcomes of PAH; a discussion of clinical trial data on existing and emerging therapeutics for the management of PAH; and a review of effective strategies to improve therapeutic and clinical outcomes in patients with PAH.

Intended Audience

This activity is intended for nurse practitioners, nurses, and other providers involved in the management of patients with PAH.

Educational Objectives

After completing this activity, participants should be able to:

  • Review the pathophysiology, classification, functional capacity classification, predictors of disease progression and clinical outcomes of PAH
  • Discuss the safety, tolerability, administration, and general use of existing and emerging therapeutics for the management of PAH
  • Identify strategies to optimize therapy and improve outcomes in patients with PAH

Conflict Of Interest Disclosure Policy

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH Inc., Advancing Knowledge in Healthcare, planners and reviewers have no relevant financial relationships to disclose.

Faculty

Sandra Lombardi, RN
Pulmonary Hypertension Clinical Nurse Coordinator
University of California, San Diego
La Jolla, CA

Sandra Lombardi has disclosed the following relevant financial relationships:
Consultant: Actelion Pharmaceuticals US, Inc., Bayer HealthCare Pharmaceuticals, Inc.
Speakers Bureau: Actelion Pharmaceuticals US, Inc., Bayer HealthCare Pharmaceuticals, Inc.

Martha Kingman, FNP-C, DNP
Nurse Practitioner, Pulmonary Services, Heart and Lung Center
University of Texas Southwestern Medical Center
Dallas, TX

Martha Kingman has disclosed the following relevant financial relationships:
Consultant: Actelion Pharmaceuticals US, Inc., Bayer HealthCare Pharmaceuticals, Inc., Gilead, United Therapeutics
Speakers Bureau: Actelion Pharmaceuticals US, Inc., Bayer HealthCare Pharmaceuticals, Inc., Gilead, United Therapeutics

Accredited Provider Disclosure

STAFF/REVIEWERS
Christopher J. Drury, MA, MA
, Medical Writer/Interviewer, has disclosed no relevant financial relationships.

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner, discloses no financial relationships with pharmaceutical or medical product manufacturers.

Bernadette Marie Makar, MSN, NP-C, APRN-C, Nurse Planner, discloses no financial relationships with pharmaceutical or medical product manufacturers.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This activity is awarded 1.0 Contact Hours.

Credit

1.00

Type

CE for Nurse Practitioners

Accreditation Statement

AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.

Designation Statement

This program is accredited for 1.0 contact hour(s) which includes 1.0 hour(s) of pharmacology. Program ID #21714.

Disclosure of Unlabeled Use

This educational activity will include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. You must participate in the entire activity to receive credit. IfYour online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact AKH at jgoldman@akhcme.com.

Privacy Policy

AKH Inc. Privacy Policy

Continuing Medical Education and Continuing Education

When you register for a Continuing Medical Education (CME) or a Continuing Education (CE) activity through one of our Web sites, we collect certain personally identifiable information from you such as your name, email address and mailing address. If you are a pharmacist and wish to receive CE credit, you are also required to provide your NAPB # and month and day of birth. For more information about NABP and CPE Monitor click here. In addition to personally identifiable information, we collect aggregated non-personally identifiable information about the activities undertaken by our users. We use the information that we collect through CME/CE activities in several ways:

  • We work with several accredited companies who are accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. As a joint-provider, we are required periodically to submit aggregated data about CME participants and the CME activities we certify. We also provide personally identifiable information to other accredited CME/CE providers who certify CME/CE activities posted on our Web sites, as required by the ACCME and other accrediting bodies. These reports may include personally identifiable information about you and credits issued to you, for the purpose of maintaining records that you can request from the accredited provider for up to six (6) years;
  • Commercial supporters of CME/CE activities on our Web site will receive only aggregated data about CME/CE activities that are relevant to their interests and/or the courses they support;
  • Our Editorial and Customer Support Staff will have internal access to files containing personally identifiable information, including evaluation forms and aggregated CME /CE participant information. These files can be accessed in order to respond to your questions or comments. Our staff may also use personally identifiable information, including registration information and evaluation data, in assessing educational needs and planning marketing activities.
We may use the information we collect as otherwise permitted in this Privacy Policy.

myCME privacy policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue